Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Optimizing the Use of Disease Modifying Therapy in Multiple Sclerosis
October 18, 2019 – 
Following perspective on cladribine in multiple sclerosis, panelists provide insight on selection and use amid disease-modifying therapy.
Siponimod's Role in Managing Multiple Sclerosis
October 18, 2019 – 
Experts home in on the benefit of siponimod, a sphingosine 1-phosphate receptor modulator, in managing multiple sclerosis.
Biochemical Versus Symptomatic Relapse Treatment Choices in MM
October 17, 2019 – 
Sundar Jagannath, MD, shares his approach to choosing the best treatment plan for patients based on genetic risk in multiple myeloma.
Managing Discrepancies in NCCN and Payer Guidelines in Multiple Myeloma
October 17, 2019 – 
The key opinion leaders discuss the need for transparency between the National Comprehensive Cancer Network (NCCN) guidelines, payer preference, and real-world patient needs in multiple myeloma.
Sickle Cell Disease: Challenges From the Payer Perspective
October 16, 2019 – 
The panelists consider remaining challenges in sickle cell disease as they relate to the payer’s role.
Sickle Cell Disease: Addressing Complications and Quality of Life
October 16, 2019 – 
A comprehensive discussion on sickle cell disease complication management that addresses disease severity and quality of life.
The Burden of Insomnia in the Elderly
October 15, 2019 – 
Key opinion leaders consider the economic and social burden of insomnia in elderly patients.
Differentiating Insomnia Subtypes
October 14, 2019 – 
Peter L. Salgo, MD, leads a discussion on the identification of insomnia and its subtypes, delving into how physicians can effectively differentiate from chronic versus acute, primary versus secondary, and comorbid settings.
Ocrelizumab Use in Treating Multiple Sclerosis
October 11, 2019 – 
A panel of experts considers the role of ocrelizumab, an anti-CD20 monoclonal antibody, in treating multiple sclerosis.
Approaching the Management of Multiple Sclerosis
October 11, 2019 – 
Focusing on the management of multiple sclerosis, the panel outlines available nonpharmacologic and pharmacologic strategies.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.